Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.65 |
| ▸ | CES2 | O00748 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MITF | O75030 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.49 |
| ▸ | CRHBP | P24387 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1140280 | 1.00 | CES1 (0.65) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL16690236 | 0.95 | POLB (0.63) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL7353197 | 0.92 | CES1 (0.59) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL12418538 | 0.84 | ACHE (0.64) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL7095150 | 0.84 | CES1 (0.62) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL13029991 | 0.84 | ACHE (0.64) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL27578404 | 0.81 | POLB (0.51) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL9670443 | 0.80 | CES1 (0.74) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL28930611 | 0.80 | CES1 (0.74) | CES1CES2TDP1POLBMAPK1 | |
| SCHEMBL28949248 | 0.80 | CES1 (0.74) | CES1CES2TDP1POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320251-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING NOVEL CYCLIC PEPTIDES | LISATA THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | claimed |
| US-20240247032-A1 | METHOD OF SYNTHESIZING DENDRIMERIC AMPHIPHILE | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2024-07-25 | — | — | US | claimed |
| EP-4392071-A1 | METHOD OF SYNTHESIZING DENDRIMERIC AMPHIPHILE | Kaohsiung Medical University (TW) | 2024-07-03 | — | — | EP | claimed |
| CN-117946306-B | Diketoxime resin, preparation method thereof and nickel removal method of lithium battery recovery liquid | 江苏海普功能材料有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117946306-A | Diketoxime resin, preparation method thereof and nickel removal method of lithium battery recovery liquid | 江苏海普功能材料有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117004836-A | Method for extracting scandium element from titanium white waste acid and red mud solution | 广西大学 | 2023-11-07 | — | — | CN | claimed |
| CN-116497528-A | Flexible conductive fiber film based on oxime urethane bond, preparation method and application | 陕西科技大学 | 2023-07-28 | — | — | CN | claimed |
| WO-2023023889-A1 | METHOD OF SYNTHESIZING DENDRIMERIC AMPHIPHILE | KAOHSIUNG MEDICAL UNIVERSITY (CN) | 2023-03-02 | — | — | WO | claimed |
| EP-4100007-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | The Regents of the University of California (US) | 2022-12-14 | — | — | EP | claimed |
| CN-115461054-A | Elongation factor 1-alpha inhibitor and application thereof | 加利福尼亚大学董事会 | 2022-12-09 | — | — | CN | claimed |
| EP-4731637-A1 | METHODS OF CHEMICAL SYNTHESIS OF PEPTIDES | Imperial College Innovations Limited (GB) | 2026-04-29 | — | — | EP | disclosed |
| EP-4727653-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727655-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727654-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4707386-A1 | ARTIFICIAL VIRUS CAPSID | AGC INC. (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20220119440-A1 | PEPTIDE AND METHOD FOR MANUFACTURING SAME | AGC Inc. (JP) | 2022-04-21 | — | — | US | disclosed |
| US-11306074-B2 | Chemical and method for analyzing DNA sequence by visualizing single-molecule DNA and use thereof | Sogang University Research Foundation (KR) | 2022-04-19 | — | — | US | disclosed |
| US-20220096594-A1 | MACROCYCLIC PEPTIDES FOR TARGETED INHIBITION OF AUTOPHAGY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-03-31 | — | — | US | disclosed |
| US-11286280-B2 | Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy | PALATIN TECHNOLOGIES, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| US-20220088146-A1 | Melanocortin Receptor-Specific Peptide Formulations and Methods for Gastrointestinal Tract-Specific Delivery | PALATIN TECHNOLOGIES INC (US) | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320251-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING NOVEL CYCLIC PEPTIDES | VIP, NGLY1, GRPR | CES1 1257/4885CES2 4223/4885TDP1 3912/4885 |
| US-11286280-B2 | Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy | MC3R, MC1R, MC2R | CES1 3705/4885CES2 4725/4885TDP1 3676/4885 |
| US-20220088146-A1 | Melanocortin Receptor-Specific Peptide Formulations and Methods for Gastrointestinal Tract-Specific Delivery | MC3R, GIPR, MC1R | CES1 2485/4885CES2 4292/4885TDP1 4749/4885 |
| US-20240247032-A1 | METHOD OF SYNTHESIZING DENDRIMERIC AMPHIPHILE | DNM2, ANXA2, ANXA6 | CES1 4569/4885CES2 3966/4885TDP1 3109/4885 |
| US-20220119440-A1 | PEPTIDE AND METHOD FOR MANUFACTURING SAME | VIP, RFC2, QRFPR | CES1 1277/4885CES2 2111/4885TDP1 4160/4885 |
| US-11306074-B2 | Chemical and method for analyzing DNA sequence by visualizing single-molecule DNA and use thereof | FEN1, POLR1A, DCLRE1A | CES1 3073/4885CES2 4716/4885TDP1 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.